Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | CBS | P35520 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | PAM | P19021 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1056083 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL29525974 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL6275021 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL22609510 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL1172675 | 0.97 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| Ethylene SCHEMBL8946643 | 0.95 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL19066801 | 0.95 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| SCHEMBL30523306 | 0.93 | ALDH1A1 (0.45) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| Ethylene Glycol SCHEMBL8984224 | 0.93 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBGLAL3MBTL1 | |
| Ethylene Glycol SCHEMBL8946650 | 0.91 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBGLAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3955937-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2022-02-23 | — | — | EP | claimed |
| WO-2020212760-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2020-10-22 | — | — | WO | claimed |
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2019-08-27 | — | — | US | claimed |
| US-9649713-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2017-05-16 | — | — | US | claimed |
| US-20170064823-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2017-03-02 | — | — | US | claimed |
| US-9532493-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2016-12-27 | — | — | US | claimed |
| EP-4651902-A2 | ASGPR BINDING COMPOUNDS AND CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250331107-A1 | ORGANIC FILM AND METHOD FOR PRODUCING SAME | SHIKOKU CHEM (JP) | 2025-10-23 | — | — | US | disclosed |
| EP-4624466-A1 | DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Innocure Therapeutics, Inc. (KR) | 2025-10-01 | — | — | EP | disclosed |
| US-20250263580-A1 | METAL SURFACE TREATMENT LIQUID | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-4580405-A1 | COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL | Oerth Bio LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20250215572-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4506488-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | Shikoku Chemicals Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | SANOFI-AVENTIS (FR) | 2007-12-20 | — | — | US | disclosed |
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1753728-A1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-02-21 | — | — | EP | disclosed |
| EP-1725577-A1 | ANTITHROMBOTIC COMPOUND | Sanofi-Aventis (FR) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005121101-A1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEMICALS CORPORATION (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005090382-A1 | ANTITHROMBOTIC COMPOUND | SANOFI-AVENTIS (FR) | 2005-09-29 | — | — | WO | disclosed |
| EP-1574516-A1 | Antithrombotic compound | Sanofi-Aventis (FR) | 2005-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | CYP1A1, CYP1A2, P4HA1 | ALDH1A1 27/4885TSHR 1326/4885THRB 2152/4885 |
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | F13B, SERPINC1, SELP | ALDH1A1 1008/4885TSHR 1149/4885THRB 1084/4885 |
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SOD1, SOD3, AOC3 | ALDH1A1 482/4885TSHR 2687/4885THRB 652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.